PRESS RELEASEStarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive CancersThe ...
Research conducted by Gustave Roussy will help StarkAge move STX-01, an antibody-drug conjugate targeting senescent cells, toward clinical trials.
In a sterile laboratory, researchers examine petri dishes containing what could be the key to extending human lifespan. These aren’t experimental stem cells or gene therapies, but rather compounds ...
Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused ...
LONDON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results